Dalbraminol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H26N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7GDN12Q42M, chemically known as (- )-1-phenoxy-3-((2-((1,3,5-trimethylpyrazol-4-yl)amino)ethyl)amino)-2-propanol. but generally known as dalbraminol, which bears US NIH Compound Identifier 205958. European Medicines Agency schedules Dalbraminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06889MIG. The term DALBRAMINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). DALBRAMINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dalbraminol under HS 29331990 and SITC 51571. As of Q4 2014, DALBRAMINOL remains the US FDA Preferred Term for this commodity. Dalbraminol bears US NLM identifiers UMLS ID C2699554 and NCI Concept Code C74200. SMILES: OC(CNCCNC1C(N(NC1C)C)C)COC1CCCCC1.